Tag
Glenmark Pharmaceuticals Limited
2 articles
Glenmark Takes Direct U.S. Control of RYALTRIS®
Glenmark Pharmaceuticals assumes end-to-end commercialization and distribution of RYALTRIS® in the U.S. effective April 1, 2026.
RYALTRIS® is Glenmark's first innovative product in the U.S., a fixed-d
Glenmark Pharma GST Demand Order ₹32 Crore
Glenmark Pharmaceuticals received a GST adjudication order for FY 2019-20 and 2020-21 from Mumbai East Commissionerate.
Order demands ₹16.05 crore GST (CGST/SGST), equivalent penalty of ₹16.05 crore,